New pill tested to save sight in rare genetic disorder
NCT ID NCT04355689
Summary
This study is testing whether an oral medication called NPI-001 can help slow down vision loss in adults with Usher syndrome, a rare genetic condition that affects both hearing and sight. About 49 participants will take either the real drug or a placebo (a pill with no medicine) for two years. Researchers will measure changes in the eye's sensitivity to light to see if the treatment is working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for USHER SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CERA
Melbourne, Australia
-
Lions Eye Institute
Perth, Australia
-
Queensland Eye Institute
Brisbane, Australia
-
Sydney Eye Hospital / Save Sight Institute
Sydney, Australia
Conditions
Explore the condition pages connected to this study.